China Pharma Holdings Inc (CPHI) — Capital Reinvestment Ratio
Latest as of June 2025:
0.03x
China Pharma Holdings Inc (CPHI) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow ($291.08K) in capital expenditures ($9.92K). See CPHI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
$291.08K
USD
Capital Expenditures
$9.92K
USD
Data as of
Jun 2025
Most recent filing
China Pharma Holdings Inc Capital Reinvestment Ratio (2007–2019)
This chart tracks China Pharma Holdings Inc's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for China Pharma Holdings Inc (2007–2019)
Year-by-year Capital Reinvestment Ratio for China Pharma Holdings Inc from 2007 to 2019. For live market cap and broader valuation context, see CPHI market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.22x | $608.31K | $136.00K | ▲ +449.5% |
| 2018 | 0.04x | $1.26 Million | $51.15K | ▼ -74.9% |
| 2017 | 0.16x | $841.22K | $136.48K | ▲ +142.9% |
| 2016 | 0.07x | $2.90 Million | $193.40K | ▼ -90.4% |
| 2015 | 0.69x | $3.35 Million | $2.32 Million | ▼ -45.8% |
| 2014 | 1.28x | $4.57 Million | $5.84 Million | ▼ -42.5% |
| 2013 | 2.22x | $8.60 Million | $19.09 Million | ▲ +62.3% |
| 2012 | 1.37x | $3.64 Million | $4.99 Million | ▲ +29.3% |
| 2011 | 1.06x | $5.24 Million | $5.54 Million | ▼ -21.7% |
| 2010 | 1.35x | $7.79 Million | $10.52 Million | ▼ -6.2% |
| 2009 | 1.44x | $10.67 Million | $15.36 Million | ▲ +10.9% |
| 2008 | 1.30x | $6.54 Million | $8.49 Million | ▲ +21.7% |
| 2007 | 1.07x | $2.80 Million | $2.99 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow